| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $103.7M | +5.8% | +29.2% |
| Cost of Revenue | $513K | -50.7% | +14.5% |
| R&D Expense | $70.6M | +2.3% | +33.7% |
| SG&A Expense | $39.8M | -7.0% | +12.0% |
| Operating Income | -$7.2M | +51.8% | +15.7% |
| Interest Expense | $3.0M | -0.1% | -29.1% |
| Pre-tax Income | $304K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $498.4M | +2.1% | -7.3% |
| Short-term Investments | $393.9M | -0.2% | +8.4% |
| Inventory | $5.7M | +3.6% | +25.2% |
| Current Assets | $1.02B | +2.1% | +1.7% |
| Total Assets | $1.10B | +1.9% | +1.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $21.9M | — | — |
| Capital Expenditures | $1.5M | — | — |
| Investing Cash Flow | -$15.5M | — | — |
| Financing Cash Flow | $8.1M | — | — |
| Free Cash Flow | $20.5M | — | — |
| +103.1% |
| -95.0% |
| Income Tax | $481K | -20.6% | +118.2% |
| Net Income | -$177K | +98.3% | -102.0% |
| EPS (Basic) | $0.00 | +100.0% | -100.0% |
| EPS (Diluted) | $0.00 | +100.0% | -100.0% |
| $170.4M |
| +0.2% |
| -36.0% |
| Total Liabilities | $705.9M | +1.7% | -0.1% |
| Stockholders' Equity | $396.6M | +2.1% | +5.0% |